PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+2.56%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.42B
AUM Growth
+$2.42B
(-6.1%)
Cap. Flow
-$170M
Cap. Flow
% of AUM
-7.04%
Top 10 Holdings %
Top 10 Hldgs %
27.69%
Holding
1,575
New
43
Increased
381
Reduced
1,048
Closed
102
Top Buys
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$11.8M |
| 2 |
AbbVie
ABBV
|
$5.53M |
| 3 |
Wells Fargo
WFC
|
$4.43M |
| 4 |
JPMorgan Chase
JPM
|
$4.1M |
| 5 |
Starbucks
SBUX
|
$3.97M |
Top Sells
| 1 |
Intel
INTC
|
$16M |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
$11.9M |
| 3 |
Texas Instruments
TXN
|
$6M |
| 4 |
GE Aerospace
GE
|
$4.59M |
| 5 |
Broadcom
AVGO
|
$3.77M |
Sector Composition
| 1 | Healthcare | 39.03% |
| 2 | Technology | 11.99% |
| 3 | Financials | 8.03% |
| 4 | Communication Services | 7.15% |
| 5 | Consumer Discretionary | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $140M | 5.8% | 1,197,042 -29,680 | -2% | -$3.47M |
|
2
Amgen
AMGN
$155B
| $95.1M | 3.94% | 619,140 -5,876 | -0.9% | -$902K |
|
|
3
AbbVie
ABBV
$372B
| $88.1M | 3.65% | 1,311,597 +82,354 | +7% | +$5.53M |
|
4
Biogen
BIIB
$19.4B
| $77.4M | 3.2% | 191,576 -1,421 | -0.7% | -$574K |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $74.8M | 3.1% | 645,962 -13,178 | -2% | -$1.53M |
|
6
Apple
AAPL
$3.45T
| $62.1M | 2.57% | 495,014 -24,348 | -5% | -$3.05M |
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $33.7M | 1.4% | 63,613 +1,269 | +2% | +$672K |
|
8
Johnson & Johnson
JNJ
$427B
| $32.8M | 1.36% | 336,483 -215 | -0.1% | -$21K |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $32.8M | 1.36% | 181,187 +14,657 | +9% | +$2.65M |
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $32M | 1.33% | 62,749 +788 | +1% | +$402K |
|
11
Microsoft
MSFT
$3.77T
| $30.6M | 1.27% | 692,764 -35,971 | -5% | -$1.59M |
|
12
Illumina
ILMN
$15.8B
| $25.1M | 1.04% | 115,019 +744 | +0.7% | +$162K |
|
13
Pfizer
PFE
$141B
| $24.7M | 1.02% | 737,779 +9,643 | +1% | +$323K |
|
14
Amazon
AMZN
$2.44T
| $24.7M | 1.02% | 56,853 +327 | +0.6% | +$142K |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $24.5M | 1.01% | 198,278 -891 | -0.4% | -$110K |
|
16
Exxon Mobil
XOM
$487B
| $23.7M | 0.98% | 284,341 +1,718 | +0.6% | +$143K |
|
17
Meta Platforms (Facebook)
META
$1.86T
| $22.3M | 0.92% | 259,746 +5,646 | +2% | +$484K |
|
18
Merck
MRK
$210B
| $19.5M | 0.81% | 342,869 -684 | -0.2% | -$38.9K |
|
|
19
Intel
INTC
$107B
| $18.8M | 0.78% | 617,753 -524,715 | -46% | -$16M |
|
20
BioMarin Pharmaceuticals
BMRN
$11.2B
| $16.4M | 0.68% | 119,729 +2,440 | +2% | +$334K |
|
|
21
Wells Fargo
WFC
$263B
| $14.8M | 0.61% | 262,614 +78,782 | +43% | +$4.43M |
|
|
22
JPMorgan Chase
JPM
$829B
| $14.3M | 0.59% | 211,406 +60,476 | +40% | +$4.1M |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $14.3M | 0.59% | 47,022 +474 | +1% | +$144K |
|
24
Comcast
CMCSA
$125B
| $14.1M | 0.58% | 234,692 -9,256 | -4% | -$557K |
|
25
Bristol-Myers Squibb
BMY
$96B
| $13.3M | 0.55% | 199,335 +2,315 | +1% | +$154K |
|